D'Orazio & Associates, Inc. Abb Vie Inc. Transaction History

D'Orazio & Associates, Inc.

$649 Million
Q2 2024

A detailed history of D'Orazio & Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, D'Orazio & Associates, Inc. holds 4,591 shares of ABBV stock, worth $903,600. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,591

Previous 4,589 0.04%

Holding current value

$903,600

Previous $835,000 5.75%

% of portfolio

0.12%

Previous 0.13%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$154.79 - $180.76 $309 - $361	2 Added 0.04%	4,591 $787,000
Q1 2024 May 08, 2024	BUY	$159.82 - $182.1 $56,736 - $64,645	355 Added 8.38%	4,589 $835,000
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $19,539 - $22,005	-142 Reduced 3.24%	4,234 $656,000
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $126,643 - $146,608	948 Added 27.65%	4,376 $652,000
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $62,677 - $77,997	-473 Reduced 12.13%	3,428 $461,000
Q1 2023 Apr 21, 2023	SELL	$144.61 - $166.54 $9,978 - $11,491	-69 Reduced 1.74%	3,901 $621,000
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $21,023 - $25,212	152 Added 3.98%	3,970 $0
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $164,675 - $188,872	1,227 Added 47.36%	3,818 $512,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $8,670 - $11,022	-63 Reduced 2.37%	2,591 $397,000
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $66,517 - $82,530	504 Added 23.44%	2,654 $430,000
Q4 2021 Feb 07, 2022	BUY	$107.43 - $135.93 $6,230 - $7,883	58 Added 2.77%	2,150 $291,000
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $19,896 - $22,585	187 Added 9.82%	2,092 $226,000
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $1,578 - $1,758	-15 Reduced 0.78%	1,905 $215,000
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $2,455 - $2,702	24 Added 1.27%	1,920 $208,000
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $15,695 - $21,190	-195 Reduced 9.33%	1,896 $203,000
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $17,096 - $20,065	199 Added 10.52%	2,091 $183,000
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $807 - $1,079	11 Added 0.58%	1,892 $186,000
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $258 - $391	4 Added 0.21%	1,881 $143,000
Q4 2019 Jan 22, 2020	BUY	$72.13 - $90.25 $360 - $451	5 Added 0.27%	1,877 $166,000
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $23,428 - $28,167	372 Added 24.8%	1,872 $142,000
Q2 2019 Aug 05, 2019	SELL	$65.7 - $83.98 $1,445 - $1,847	-22 Reduced 1.45%	1,500 $109,000
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $117,407 - $138,182	1,522 New	1,522 $123,000
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $15,414 - $19,009	-198 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $177 - $197	2 Added 1.02%	198 $19,000
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $17,596 - $20,821	196 New	196 $18,000

Others Institutions Holding ABBV

# of Institutions

3,696

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $348B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on D'Orazio & Associates, Inc. with notifications on news.

Account

D'Orazio & Associates, Inc. Abb Vie Inc. Transaction History